RT Journal Article
SR Electronic
T1 Predicting human health from biofluid-based metabolomics using machine learning
JF medRxiv
FD Cold Spring Harbor Laboratory Press
SP 2020.01.29.20019471
DO 10.1101/2020.01.29.20019471
A1 Evans, Ethan D.
A1 Duvallet, Claire
A1 Chu, Nathaniel D.
A1 Oberst, Michael K.
A1 Murphy, Michael A.
A1 Rockafellow, Isaac
A1 Sontag, David
A1 Alm, Eric J.
YR 2020
UL http://medrxiv.org/content/early/2020/02/03/2020.01.29.20019471.abstract
AB Biofluid-based metabolomics enables the profiling of thousands of molecules and has the potential to provide highly accurate, minimally invasive diagnostics for a range of health conditions. However, typical metabolomics studies focus on only a few statistically significant features. We study the applicability of machine learning for health state-prediction across 35 human mass spectrometry-based metabolomics studies. Models trained on all features outperform those using only significant features and frequently provide high predictive performance across nine health states, despite disparate experimental conditions and disease contexts. Combining data from different experimental settings (e.g. sample type, instrument, chromatography) within a study minimally alters predictive performance, suggesting information overlap between different methods. Using only non-significant features, we still often obtain high predictive performance. To facilitate further advances, we provide all data online. This work highlights the applicability of biofluid-based metabolomics with data-driven analysis for health state diagnostics.Competing Interest StatementThe authors have declared no competing interest.Funding StatementThis work was supported by The Abdul Latif Jameel Clinic for Machine Learning in Health at MIT (J-Clinic) as well as the Center for Microbiome Informatics and Therapeutics (CMIT).Author DeclarationsAll relevant ethical guidelines have been followed; any necessary IRB and/or ethics committee approvals have been obtained and details of the IRB/oversight body are included in the manuscript.YesAll necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.YesAll mass spectrometry data used is freely available and listed in Table S1. Packaged data sets .pkl and input feature with matched label .csv files, along with model training output .csv and .pkl files will be deposited in Zenodo upon publication.